Quince Therapeutics Inc QNCX

US Biotechnology

$31.00 ▲ +3.33% (+$1.00)

Open $30.40

Prev Close $30.00

Day Range $29.98 – $31.00

52W Range $15.10 – $910.00

Market Cap $31.53M

Beta 1.80

EPS (TTM) $-125.71

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2019-05-09
Shares Out.	980,000
Website	quincetx.com/ ↗
Phone	14159105717
Employees	38
Revenue	$0
Gross Profit	$0
Net Income	-$75.5M
Free Cash Flow	-$47.0M
Total Assets	$124.0M
Total Liabilities	$15.5M
Equity	$108.5M

About Quince Therapeutics Inc

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Quince Therapeutics Inc is a publicly traded company under the ticker symbol QNCX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.